USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection Sep. 14, 2021 No Comments
Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections Sep. 10, 2021 No Comments
IMM-BCP-01 neutralizes SARS-CoV-2 Lambda and Delta Plus variants in preclinical tests Sep. 8, 2021 No Comments
RSS